Japan Deep Brain Stimulation Devices Market Size & Outlook

The deep brain stimulation devices market in Japan is expected to reach a projected revenue of US$ 90.4 million by 2030. A compound annual growth rate of 11.2% is expected of Japan deep brain stimulation devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$42.9
Forecast, 2030 (US$M)
$90.4
CAGR, 2024 - 2030
11.2%
Report Coverage
Japan

Japan deep brain stimulation devices market, 2018-2030 (US$M)

Japan

Related Markets

Japan deep brain stimulation devices market highlights

  • The Japan deep brain stimulation devices market generated a revenue of USD 42.9 million in 2023 and is expected to reach USD 90.4 million by 2030.
  • The Japan market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
  • In terms of segment, dual channel was the largest revenue generating product in 2023.
  • Single Channel is the most lucrative product segment registering the fastest growth during the forecast period.


Deep brain stimulation devices market data book summary

Market revenue in 2023USD 42.9 million
Market revenue in 2030USD 90.4 million
Growth rate11.2% (CAGR from 2023 to 2030)
Largest segmentDual channel
Fastest growing segmentSingle Channel
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSingle Channel, Dual Channel
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc


Other key industry trends

  • In terms of revenue, Japan accounted for 3.7% of the global deep brain stimulation devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
  • Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.

Dual channel was the largest segment with a revenue share of 56.88% in 2023. Horizon Databook has segmented the Japan deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.


Long-term cost-effectiveness associated with deep brain stimulation devices is a high-impact rendering driver of Japan market. According to a study published in NCBI, deep brain stimulation is a cost-effective procedure and delivers sustained benefits.

Hence, it is preferred over other conventional treatment options. Major companies operating in Japan deep brain stimulation devices market include Shenzhen Yingchi Technology Co. Ltd., Medtronic plc, Abbott, and Boston Scientific Corp., among others.

Moreover, technological innovations, such as incorporation of robotic assistance, to minimize human errors during surgeries and extensive R&D capabilities are responsible for the country’s largest market share in Asia Pacific.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Deep Brain Stimulation Devices Market Companies

Name Profile # Employees HQ Website

Japan deep brain stimulation devices market size, by product, 2018-2030 (US$M)

Japan Deep Brain Stimulation Devices Market Outlook Share, 2023 & 2030 (US$M)

Japan deep brain stimulation devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more